CANSF (Willow Biosciences) EBIT per Share : $-0.04 (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Willow Biosciences EBIT per Share?

Willow Biosciences's EBIT per Share for the three months ended in Sep. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.04.

During the past 3 years, the average EBIT per Share Growth Rate was 19.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 27.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 48.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Willow Biosciences's EBIT per Share or its related term are showing as below:

CANSF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -114.4 Med: 24.25 Max: 67.6
Current: 19.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Willow Biosciences was 67.60% per year. The lowest was -114.40% per year. And the median was 24.25% per year.

CANSF's 3-Year EBIT Growth Rate is ranked better than
68.3% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs CANSF: 19.20

Willow Biosciences's EBIT for the three months ended in Sep. 2024 was $-0.76 Mil.

Willow Biosciences EBIT per Share Historical Data

The historical data trend for Willow Biosciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences EBIT per Share Chart

Willow Biosciences Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.49

-0.32

-0.04

-0.09

-0.08

Willow Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Willow Biosciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Willow Biosciences's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.609	/	124.243
=	-0.08

Willow Biosciences's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.76	/	141.136
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04

Willow Biosciences (OTCPK:CANSF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Willow Biosciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

WLLW:Canada

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.